Akouos Inc.

3.97-0.2400-5.70%Vol 2.81M1Y Perf -68.56%
Jun 24th, 2022 16:00 DELAYED
BID2.35 ASK4.04
Open4.29 Previous Close4.21
Pre-Market- After-Market3.97
 - -  - -%
Target Price
15.67 
Analyst Rating
Strong Buy 1.50
Potential %
294.71 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
12.79 
Earnings Rating
Market Cap137.47M 
Earnings Date
11th Aug 2022
Alpha-0.09 Standard Deviation0.16
Beta1.52 

Today's Price Range

3.694.95

52W Range

2.3215.26

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
9.97%
1 Month
61.38%
3 Months
-17.46%
6 Months
-55.64%
1 Year
-68.56%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AKUS3.97-0.2400-5.70
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.73-0.78-6.85
Q04 2021-0.66-0.72-9.09
Q03 2021-0.63-0.67-6.35
Q02 2021-0.48-0.66-37.50
Q01 2021-0.38-0.47-23.68
Q04 2020-0.49-0.3724.49
Q03 2020-0.39-0.85-117.95
Q02 2020--11.14-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Aug 2022
Estimated EPS Next Report-0.76
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume2.81M
Shares Outstanding34.63K
Shares Float21.58M
Trades Count4.81K
Dollar Volume11.23M
Avg. Volume139.49K
Avg. Weekly Volume144.97K
Avg. Monthly Volume130.89K
Avg. Quarterly Volume142.63K

Akouos Inc. (NASDAQ: AKUS) stock closed at 3.97 per share at the end of the most recent trading day (a -5.7% change compared to the prior day closing price) with a volume of 2.81M shares and market capitalization of 137.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 69 people. Akouos Inc. CEO is Emmanuel Simons.

The one-year performance of Akouos Inc. stock is -68.56%, while year-to-date (YTD) performance is -53.29%. AKUS stock has a five-year performance of %. Its 52-week range is between 2.315 and 15.2564, which gives AKUS stock a 52-week price range ratio of 12.79%

Akouos Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 0.60, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -33.77%, a ROC of -35.84% and a ROE of -38.58%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Akouos Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.76 for the next earnings report. Akouos Inc.’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for Akouos Inc. is Strong Buy (1.5), with a target price of $15.67, which is +294.71% compared to the current price. The earnings rating for Akouos Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Akouos Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Akouos Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 24.05, ATR14 : 0.50, CCI20 : 73.71, Chaikin Money Flow : -0.18, MACD : 0.17, Money Flow Index : 85.95, ROC : -7.46, RSI : 54.98, STOCH (14,3) : 46.39, STOCH RSI : 0.70, UO : 46.50, Williams %R : -53.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Akouos Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

Akouos Inc.

Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.

CEO: Emmanuel Simons

Telephone: +1 857 410-1818

Address: 645 Summer Street, Boston 02210, MA, US

Number of employees: 69

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

60%40%

Bearish Bullish

63%37%

Bearish Bullish

63%38%

TipRanks News for AKUS

Tue, 29 Mar 2022 14:45 GMT Analysts Offer Insights on Healthcare Companies: AKOUOS (AKUS) and Humacyte (HUMA)

- TipRanks. All rights reserved.

News

Stocktwits